相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitors paradoxically prime kinases
Stephen V. Frye et al.
NATURE CHEMICAL BIOLOGY (2009)
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft
Rana P. Singh et al.
CARCINOGENESIS (2007)
Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model
Komal Raina et al.
CANCER RESEARCH (2007)
Flavopiridol in the treatment of chronic lymphocytic leukemia
Beth A. Christian et al.
CURRENT OPINION IN ONCOLOGY (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
A high-throughput screen for aggregation-based inhibition in a large compound library
Brian Y. Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo
L. Bagella et al.
ONCOGENE (2007)
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
C. Benson et al.
BRITISH JOURNAL OF CANCER (2007)
Development and validation of a modular, extensible docking program: DOCK 5
Demetri T. Moustakas et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division
ER Lacy et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
New insights into cyclins, CDKs, and cell cycle control
I Sánchez et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Cyclins and cdks in development and cancer: a perspective
A Deshpande et al.
ONCOGENE (2005)
Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6
M Malumbres et al.
CELL (2004)
Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes
A Chytil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes
MJI Andrews et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Cdk2 knockout mice are viable
C Berthet et al.
CURRENT BIOLOGY (2003)
A specific mechanism of nonspecific inhibition
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Localization and dynamics of Cdc2-cyclin B during meiotic reinitiation in starfish oocytes
M Terasaki et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Cyclin aggregation and robustness of bio-switching
BM Slepchenko et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Rapamycin potentiates transforming growth factor β-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells
BK Law et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Hassles with taking out the garbage: Aggravating aggresomes
R Garcia-Mata et al.
TRAFFIC (2002)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
